Medwatch Alert: FDA Requires Safety Labeling Changes For Glucagon-like Peptide-1 Receptor Agonists (glp-1 Ras) Due To Potential Increased Risk Of Rare But Serious Eye Condition: FDA Safety Communicati
- Product
- Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication
- Reason
- FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication
- Category
- drug recall
- Country
- United States
- Agency
- FDA-MEDWATCH-RSS
- Recall date
- 2026-11-09
- Status
- Ongoing
Official recall notice from FDA-MEDWATCH-RSS
Recall details on Nibble Recalls: https://trynibble.app/recalls/8e715b5d-fb12-48ff-8ea0-6968b443ba60